[Consensus on management of dyslipidemia in pediatrics]

Area of Science:

• Pediatrics
• Cardiovascular Health
• Metabolic Disorders

Background:

• Atherosclerosis, a precursor to cardiovascular disease, begins in childhood.
• Dyslipidemia is a key risk factor accelerating atherosclerotic progression.
• Early identification and management of pediatric dyslipidemia are vital for long-term health.

Framework:

• Proposes universal dyslipidemia screening at ages 6 and 17.
• Recommends selective screening for children over 2 with risk factors or predisposing conditions.
• Advocates for fasting blood tests including total cholesterol, LDL, HDL, and triglycerides.

Implementation:

• Pediatricians are central to screening, diagnosis, and initiating lipid-lowering strategies.
• Treatment focuses on reducing risks of premature cardiovascular events (hypercholesterolemia) and pancreatitis (severe hypertriglyceridemia).
• Referral to specialists is advised for patients with significantly elevated lipid levels requiring drug therapy.

Implications:

• Establishes a framework for pediatric dyslipidemia management.
• Aims to reduce the burden of adult cardiovascular disease through childhood interventions.
• Highlights the pediatrician's role in preventing chronic diseases through early lipid management.